ArticleHeliyon2024
Multi class robust brain tumor with hybrid classification using DTA algorithm.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 18 citations in OpenAlex.
- MM FD ConvFormer multimodal frequency aware deformable CNN transformer network for robust brain tumor classification.Scientific reports · 2026Article
- Advanced finite segmentation model with hybrid classifier learning for high-precision brain tumor delineation in PET imaging.Scientific reports · 2025Article
- Beyond visual inspection: the deep learning revolution in quantitative cerebrovascular imaging.Frontiers in neuroscience · 2025Review
- An efficient brain tumor detection and classification using pre-trained convolutional neural network models.Heliyon · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Analyzing brain tumours is important for prompt diagnosis and efficient patient care. The morphology of tumours, which includes their size, location, texture, and heteromorphic appearance in medical pictures, makes them difficult to analyse. A unique two-phase deep learning-based framework is suggested in this respect to recognise and classify brain cancers in magnetic resonance images (MRIs). A new DTA approach is suggested in the first phase to successfully identify tumour MRI images from healthy persons. DTA are specifically designed and perform well are used to create the deep boosted feature space, which is then fed into the group of machine learning (ML) classifiers. In the second stage, a brand-new hybrid features fusion-based brain tumour classification technique is put forward, one that makes use of both static and dynamic features as well as an ML classifier to classify various tumour kinds. The proposed algorithm, which can recognise the heteromorphic and variable behaviour of different tumours, is where the dynamic characteristics are taken.In this paper, many segmentation algorithms for MRI and PET are reviewed together with their performance evaluations in order to detect brain tumours. There are numerous segmentation methods available for the diagnosis of medical images. The features of the image, such as the capacity to distinguish between similarities and discontinuities, are often used to classify the segmentation techniques. Neuroradiologists have a difficult issue in trying to quickly identify the abnormal region, which is essential in the medical field. In order to overcome this problem, the efficiency of different segmentation procedures is assessed. The segmentation methods considered here are Ant Colony Optimization (ACO), Wavelet Transform (WT), Gradient Vector Flow (GVF), Gray level Co-occurrence matrix (GLCM), and Artificial Bee Colony (ABC). The various performance metrics are used to evaluate the suggested segmentation algorithms. The GVF strategy works better with MRI images, whereas the ABC and ACO approaches perform similarly with PET scans, according to the data acquired.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.